Skip to main content
Clinical Trials/NCT01422941
NCT01422941
Completed
Phase 1

A PROSPECTIVE, MULTI-CENTER CLINICAL EVALUATION TO ASSESS SAFETY AND PERFORMANCE OF CAVU MEDICAL, INC.'S ATTUNE TUBING WHEN USED WITH NEWLY-IMPLANTED LAPAROSCOPIC ADJUSTABLE GASTRIC BANDS (LAGBs)

Cavu Medical, Inc.2 sites in 1 country40 target enrollmentOctober 2010
ConditionsObesity

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Obesity
Sponsor
Cavu Medical, Inc.
Enrollment
40
Locations
2
Primary Endpoint
The rate of successful placement and filling of the CAVU Medical Attune device without serious device-related adverse events.
Status
Completed
Last Updated
10 years ago

Overview

Brief Summary

The objectives of this clinical research project are to demonstrate the safety and feasibility of CAVU Medical, Inc.'s Attune Device.

Registry
clinicaltrials.gov
Start Date
October 2010
End Date
June 2011
Last Updated
10 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Sponsor
Cavu Medical, Inc.
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • The subject is at least 18 years of age.
  • The subject has been informed of the nature of the trial and agrees to its provisions.
  • The subject has a pre-implantation BMI within the protocol limits.
  • The subject agrees to the follow-up visit schedule.
  • The subject is a candidate for a LAGB procedure.
  • The subject agrees to comply with specified follow-up evaluations.
  • The subject is willing to fast for 2 hours prior to each adjustment visit.

Exclusion Criteria

  • The subject is pregnant or is not willing to use an effective method of birth control for the duration of the trial.
  • The subject has a condition that is contraindicated for LAGB procedures.
  • The subject is currently using weight loss medications or supplements.
  • The subject has a concurrent terminal medical condition with a life expectancy of less than 12 months.
  • The subject is currently participating in an investigational drug or another medical device trial.
  • The subject had a previous LAGB procedure.
  • The Investigator believes that the patient has physical or mental conditions that would render trial participation inappropriate.

Outcomes

Primary Outcomes

The rate of successful placement and filling of the CAVU Medical Attune device without serious device-related adverse events.

Time Frame: 30 Days

Study Sites (2)

Loading locations...

Similar Trials